The population across developed countries is getting older and the associated frailty and debilitation are becoming major health problems. This gradual muscle loss is accelerated by the poor ...

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.

The first-in-human trial is testing a highly unconventional method: delivering fat-derived stem cells from the patient directly into the brain to stimulate repair and regeneration of damaged neurons.

Duke University terminates stem cell partnership with Cryo-Cell International amid $100 million arbitration claim and alleged agreement breaches.

Model more closely replicates natural environment of the pancreas, which will be essential for studying diabetes and developing new treatments.

Blue Label Telecoms, the majority shareholder of Cell C, is mulling the possible listing of the mobile operator on the Johannesburg Stock Exchange (JSE) as it restructures its business.

Huntsman Cancer Institute pioneers the first deceased donor stem cell transplant in a clinical trial—aimed at expanding access to lifesaving treatment for patients with blood cancers.

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

The aim of this open-label, multicenter, randomized controlled trial was to determine the efficacy and safety of sequential umbilical cord–derived mesenchymal stem cell (UC-MSC) infusion for ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

In the new study, Paz and her collaborators tested a stem cell therapy under development by SanBio. One month after rats had a stroke, the scientists injected the modified human stem cells into ...

Stem-cell therapies that work: 10 Breakthrough Technologies 2025 After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.